Tag: PASSION
PASSION Results Support Further Study of Camrelizumab Plus Apatinib in SCLC
By Kara Nyberg, PhD
Posted: June 24, 2020
The phase II PASSION trial sought to explore the potential synergy between immunotherapy and antiangiogenic drug therapy previously...
